Skip to Content

New Drug Approvals Archive - July 2005

July 2005

Rozerem (ramelteon) Tablets

Date of Approval: July 22, 2005
Company: Takeda Pharmaceuticals North America, Inc.
Treatment for: Insomnia

Rozerem (ramelteon) is an orally active hypnotic indicated for the treatment of insomnia characterized by difficulty with sleep onset.

Read more: Rozerem (ramelteon) FDA Approval History

New Drug Approvals Archive